WO2012108747A3 - Composition and cosmetic composition for treating brain cancer comprising helena root extract - Google Patents

Composition and cosmetic composition for treating brain cancer comprising helena root extract Download PDF

Info

Publication number
WO2012108747A3
WO2012108747A3 PCT/KR2012/001081 KR2012001081W WO2012108747A3 WO 2012108747 A3 WO2012108747 A3 WO 2012108747A3 KR 2012001081 W KR2012001081 W KR 2012001081W WO 2012108747 A3 WO2012108747 A3 WO 2012108747A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
brain cancer
helena
cosmetic composition
treating brain
Prior art date
Application number
PCT/KR2012/001081
Other languages
French (fr)
Korean (ko)
Other versions
WO2012108747A2 (en
Inventor
황성연
정경채
Original Assignee
주식회사 한국전통의학연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 한국전통의학연구소 filed Critical 주식회사 한국전통의학연구소
Publication of WO2012108747A2 publication Critical patent/WO2012108747A2/en
Publication of WO2012108747A3 publication Critical patent/WO2012108747A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/264—Aristolochia (Dutchman's pipe)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a novel use of Helena root extract, and more specifically, relates to a composition for preventing and treating brain cancer, the composition comprising Helena root ethanol extract as an active ingredient, and to a cosmetic composition for preventing brain cancer, the cosmetic composition comprising the Helena root ethanol extract, which includes a cosmetologically acceptable cosmetic supplement additive, as an active ingredient. The composition and the cosmetic composition for treating brain cancer according to the present invention are effective in inhibiting growth and inducing death of cancer cells, and thereby, can be effectively used in treating and preventing brain cancer.
PCT/KR2012/001081 2011-02-11 2012-02-13 Composition and cosmetic composition for treating brain cancer comprising helena root extract WO2012108747A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0012221 2011-02-11
KR1020110012221A KR20120092281A (en) 2011-02-11 2011-02-11 Composition for treatment of brain cancers and beauty expenses composition comprising extract of inula helenium

Publications (2)

Publication Number Publication Date
WO2012108747A2 WO2012108747A2 (en) 2012-08-16
WO2012108747A3 true WO2012108747A3 (en) 2012-12-27

Family

ID=46639102

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/001081 WO2012108747A2 (en) 2011-02-11 2012-02-13 Composition and cosmetic composition for treating brain cancer comprising helena root extract

Country Status (2)

Country Link
KR (1) KR20120092281A (en)
WO (1) WO2012108747A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014077436A1 (en) * 2012-11-16 2014-05-22 주식회사 한국전통의학연구소 Composition containing inulae radix extract for pancreatic cancer treatment and cosmetics
WO2014077435A1 (en) * 2012-11-16 2014-05-22 주식회사 한국전통의학연구소 Composition containing inulae radix extract for renal cancer treatment cosmetics
WO2015130081A1 (en) * 2014-02-25 2015-09-03 서울대학교산학협력단 Pharmaceutical composition for preventing and treating breast cancer containing inula helenium hexane fraction having stat3 inhibitory activity or compound isolated therefrom as active ingredient

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004302A1 (en) * 2004-10-15 2009-01-01 Biopharmacopae Design International Inc. Methods and Therapeutic Compositions Comprising Plant Extracts for the Treatment of Cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004302A1 (en) * 2004-10-15 2009-01-01 Biopharmacopae Design International Inc. Methods and Therapeutic Compositions Comprising Plant Extracts for the Treatment of Cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEN, C. N. ET AL.: "Isocostunolide, a sesquiterpene lactone, induces mitochondrial membrane depolarization and caspase-dependent apoptosis in human melanoma cells.", CANCER LETTERS., vol. 246, no. 1-2, February 2007 (2007-02-01), pages 237 - 252 *
DORN, D. C. ET AL.: "Tumor cell specific toxicity of Inula helenium extracts.", PHYTOTHERAPY RESEARCH, vol. 20, no. 11, November 2006 (2006-11-01), pages 970 - 980 *
KIM, J. H. ET AL.: "Anticancer Effects of Natural Medicinal Plant Extracts on Oral Carcinoma Cells.", THE JOURNAL OF APPLIED PHARMACOLOGY., vol. 7, no. 2, June 1999 (1999-06-01), pages 153 - 157 *
KONISHI, T ET AL.: "Antiproliferative sesquiterpene lactones from the roots of Inula heleium.", BIOL PHARM BULL., vol. 25, no. 10, October 2002 (2002-10-01), pages 1370 - 1372 *

Also Published As

Publication number Publication date
WO2012108747A2 (en) 2012-08-16
KR20120092281A (en) 2012-08-21

Similar Documents

Publication Publication Date Title
WO2012065121A3 (en) Metabolized conditioned growth medium and methods of use
IN2014MN02269A (en)
WO2012040804A3 (en) Synergistic combinations of triazoles, strobilurins and benzimidazoles, uses, formulations, production processes and applications using the same
EP2575842A4 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
WO2012134169A3 (en) Composition for lung cancer treatment and functional food containing gleditsiae semen extract
WO2012108749A3 (en) Composition and health functional food for treating brain cancer comprising pharbitidis semen extract
WO2013028904A3 (en) Dermal filler compositions including antioxidants
WO2012108748A3 (en) Composition and cosmetic composition for treating brain cancer comprising albizzia julibrissin extract
WO2012001246A3 (en) Use of a peptidic pea extract as an active antioxidant in a cosmetic composition
WO2013190542A3 (en) Topical compositions for the treatment of chronic inflammatory skin disease
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract
WO2013100718A3 (en) Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
WO2014023649A3 (en) Dermal cosmetic compositions having osmoprotecting activity
WO2012036414A3 (en) Cosmetic composition comprising a fermented soybean extract fraction as an active ingredient
MY170724A (en) Use of certain trioxygenated benzene derivatives in body fat management
WO2012108746A3 (en) Composition and cosmetic composition for treating brain cancer comprising rubia cordifolia root extract
WO2012108743A3 (en) Composition and cosmetic composition for treating brain cancer comprising white pharbitis seed extract
WO2012108744A3 (en) Composition and health functional food for treating brain cancer comprising inula flower extract
WO2012108745A3 (en) Composition and health functional food for treating brain cancer comprising gleditsiae semen extract
MX2014010926A (en) Herbal composition for the treatment of metabolic disorders.
WO2012169860A3 (en) Composition for preventing hair loss or promoting hair restoration, comprising soy extract
WO2012134252A3 (en) Composition for renal cancer treatment and functional food containing cannabis semen extract
WO2012108742A3 (en) Composition and health functional food for treating brain cancer comprising tussilago farfara l. flower extract
WO2012099420A3 (en) Composition and functional health food comprising elecampane extracts for treating brain cancer
WO2012134250A3 (en) Composition for renal cancer treatment and composition for cosmetic containing nardostachyos rhizoma extract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12744992

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12744992

Country of ref document: EP

Kind code of ref document: A2